CheckEye
CheckEye is an AI-driven platform focused on the mass screening of chronic diseases to enable preventive healthcare globally. Their cloud-based solution uses advanced ML/AI algorithms to detect a wide range of chronic diseases, including diabetic retinopathy, from eye fundus photographs. These photographs can be taken by non-medical staff in various locations, making early detection and prevention accessible. The platform aims to reduce waiting times for patients, improve cost efficiency, and provide more quality time for eye health professionals by automating routine screenings. Public health systems benefit from lower screening costs and more accurate diagnoses, enabling better prioritization of patient treatment. The company operates with an international team based in the UK, Ukraine, and Switzerland.
CheckEye
CheckEye is an AI-driven platform focused on the mass screening of chronic diseases to enable preventive healthcare globally. Their cloud-based solution uses advanced ML/AI algorithms to detect a wide range of chronic diseases, including diabetic retinopathy, from eye fundus photographs. These photographs can be taken by non-medical staff in various locations, making early detection and prevention accessible. The platform aims to reduce waiting times for patients, improve cost efficiency, and provide more quality time for eye health professionals by automating routine screenings. Public health systems benefit from lower screening costs and more accurate diagnoses, enabling better prioritization of patient treatment. The company operates with an international team based in the UK, Ukraine, and Switzerland.
TL;DR
What they do: AI-driven cloud platform that analyzes eye fundus photographs for mass screening and early detection of chronic diseases (initial focus: diabetic retinopathy).
Founded: 2022
Headquarters: Kyiv, Ukraine
Funding highlights: At least a $100,000 grant from Google for Startups (May 2025); additional grants and a strategic investment from Marien Apotheke.
Founders: Kirill (Kyrylo) Goncharuk; Andrii Korol; Victoria Chuchina; Mykhailo Shuranov
Company Overview
Problem Domain
Mass screening for diabetic retinopathy and chronic disease prevention using retinal/fundus imaging.
Founded
2022
Industry
HealthTech; medical diagnostics
Tech Stack
Funding Track Record
100000 USD
Grant recorded in May 2025.
Financial support announced; amount not disclosed.
Strategic investment to support scaling and wider implementation.
Investor Signal
“Has received grants from Google for Startups, WNISEF and the Ukrainian Startup Fund, and a strategic investment from Marien Apotheke; Crunchbase listings also include Seeds of Bravery.”